Go to ...

Boston News Globe

News Network

RSS Feed

July 21, 2018

Waltham biotech Visterra acquired by Japan's Otsuka for $430M


Waltham-based infectious disease biotech Visterra has agreed to be acquired by Japanese drugmaker Otsuka Pharmaceutical Co. Ltd. for $430 million.

Under the deal announced on Wednesday, Visterra will become a subsidiary of Otsuka’s U.S. holding company, and will retain its staff and location in Waltham. The transaction is expected to close in the third quarter of this year.

A spokesperson said that the company now has about 50 employees.

Tokyo-based Otsuka, by contrast, has 46,000 employees globally,…


Source: Boston Biz

More Stories From Money